CorDx to Launch 10-Minute Solution for Distinguishing Flu A/B, COVID-19 As Cases Surge Across U.S.

Against the backdrop of a concerning surge in respiratory diseases leading to widespread alarm across the United States, CorDx has submitted its application for its ⁠CorDx TyFast Flu A/B & COVID-19 Multiplex Rapid Test for FDA’s review. This cutting-edge multiplex test aims to deliver results in just 10 minutes and establishes a new benchmark for detecting and distinguishing the nucleocapsid protein antigens of COVID-19, influenza A, and influenza B.